Literature DB >> 1070842

Ocular sarcoidosis.

D G James, E Neville, D A Langley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1070842

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


× No keyword cloud information.
  13 in total

1.  Nodular scleritis in a patient with sarcoidosis.

Authors:  A Heiligenhaus; D Michel; J M Koch
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

2.  Sarcoidosis--a serious enigma.

Authors:  W J Dinning
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

Review 3.  Current approach in the diagnosis and management of panuveitis.

Authors:  Reema Bansal; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

4.  Sarcoidosis with complications.

Authors:  Andreu Fernández-Codina; Carmen Aleman; Macarena Simón-Talero; Maria Teresa Salcedo-Allende; Iago Pinal-Fernández; Antonio Segura-García
Journal:  Intern Emerg Med       Date:  2014-03-12       Impact factor: 3.397

Review 5.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

6.  Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Toshihide Ariga; Satoru Kase; Kauzhiko Yoshida; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

7.  Fundus changes in histologically confirmed sarcoidosis.

Authors:  D J Spalton; M D Sanders
Journal:  Br J Ophthalmol       Date:  1981-05       Impact factor: 4.638

Review 8.  Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.

Authors:  Neal V Palejwala; Steven Yeh; Sheila T Angeles-Han
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

9.  Fundus pathology in neurosarcoidosis.

Authors:  C J Brinkman; A Rothova
Journal:  Int Ophthalmol       Date:  1993-02       Impact factor: 2.031

10.  Risk factors for ocular sarcoidosis.

Authors:  A Rothova; C Alberts; E Glasius; A Kijlstra; H J Buitenhuis; A C Breebaart
Journal:  Doc Ophthalmol       Date:  1989-08       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.